Zensar Technologies (504067) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
2 Nov, 2025Executive summary
Achieved Q2 FY26 revenue of $162.8M, up 4.2% YoY and 0.5% sequentially, with margin expansion and disciplined execution.
Launched the Zensai AI platform, updated the website, and highlighted AI-driven project wins across multiple sectors.
Maintained a client-centric strategy, adapting to global shifts and leading with AI.
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, were approved by the Board.
Independent auditors reviewed results with no material misstatements identified.
Financial highlights
Q2 FY26 revenue was $162.8M (₹14,213M), up 4.2% YoY; consolidated net profit was ₹1,822M, up from ₹1,557M YoY.
Gross margin improved to 31%, up 50 bps QoQ; EBITDA margin rose to 15.4%, up 20 bps sequentially.
Diluted EPS grew to INR 7.9 per share, a 16.2% YoY increase; basic EPS (consolidated) for Q2 FY26 was ₹8.02.
Cash and investments totaled $293M post-dividend payout; cash and cash equivalents (consolidated) as of September 30, 2025, stood at ₹3,741M.
Net cash generated from operating activities (consolidated) for H1 FY26 was ₹3,069M, up from ₹1,723M in H1 FY25.
Outlook and guidance
Management remains positive on business outlook except for TMT headwinds, with a strong qualified pipeline and focus on execution.
Q3 expected to be seasonally weak due to industry-wide furloughs, but reduced TMT exposure should mitigate impact.
Committed to maintaining mid-teen EBITDA margins, with flexibility for investments.
The Board highlighted continued growth in both revenue and profitability year-over-year.
Latest events from Zensar Technologies
- Q1 FY27 revenue up to $159.5M, EBITDA margin down, BFSI and AI drive growth, cash strong.504067
Q1 26/2730 Jul 2026 - Q3 FY25 revenue up 8.6% YoY to $157.0M, with 15.6% EBITDA margin and record order book.504067
Q3 24/259 Jul 2026 - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/268 Jul 2026 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/258 Jul 2026 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/2519 Jun 2026 - Q1 FY26 revenue up 4.9% YoY to $162M, with strong AI and digital/cloud growth but margin pressures.504067
Q1 25/2619 Jun 2026 - AI-driven growth, robust financials, and ESG leadership marked FY26 performance.504067
Investor presentation26 May 2026 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/2623 Jan 2026